Nolan IT, Dy GW, Levitt N. Considerations in gender-affirming surgery: demographic trends. Urol Clin North Am. 2019;46(4):459-465.
Meerwijk EL, Sevelius JM. Transgender population size in the United States: a meta-regression of population-based probability samples. Am J Public Health. 2017;107(2):e1-e8.
Canner JK, Harfouch O, Kodadek LM, et al. Temporal trends in gender-affirming surgery among transgender patients in the United States. JAMA Surg. 2018;153(7):609-616.
Coleman E, Radix AE, Bouman WP, et al. Standards of care for the health of transgender and gender diverse people, version 8. Int J Transgend Health. 2022;23(suppl 1):S1-S259.
James SE, Herman JL. Rankin S, et al. The report of the 2015 U.S. transgender survey. National Center for Transgender Equality; 2016. Accessed August 3, 2023. https://transequality.org/sites/default/files/docs/usts/USTS-Full-Report-Dec17.pdf
Safer JD, Coleman E, Feldman J, et al. Barriers to healthcare for transgender individuals. Curr Opin Endocrinol Diabetes Obes. 2016;23(2):168-171.
van Heesewijk J, Kent A, van de Grift TC, et al. Transgender health content in medical education: a theory-guided systematic review of current training practices and implementation barriers & facilitators. Adv Health Sci Educ Theory Pract. 2022;27(3):817-846.
Thawanyarat K, Johnstone T, Rowley M, et al. Travel distance and national access to gender-affirming care. J Am Coll Surg. 2022;235(5):S212.
Grasso C, Goldhammer H, Thompson J, et al. Optimizing gender-affirming medical care through anatomical inventories, clinical decision support, and population health management in electronic health record systems. J Am Med Inform Assoc. 2021;28(11):2531-2535.
Deutsch MB. Guidelines for the primary and gender-affirming care of transgender and gender nonbinary people, 2nd ed. University of California–San Francisco, June 17, 2016. Accessed August 3, 2023. https://transcare.ucsf.edu/guidelines
Schrager S, Lyon SM, Poore SO. Breast implants: common questions and answers. Am Fam Physician. 2021;104(5):500-508.
Klein DA, Paradise SL, Goodwin ET. Caring for transgender and gender-diverse persons: what clinicians should know. Am Fam Physician. 2018;98(11):645-653.
Dakkak M, Kriegel DL, Tauches K. Caring for transgender and gender-diverse people: guidelines from WPATH. Am Fam Physician. 2023;108(6):626-629.
Oles N, Darrach H, Landford W, et al. Gender affirming surgery: a comprehensive, systematic review of all peer-reviewed literature and methods of assessing patient-centered outcomes (part 1: breast/chest, face, and voice). Ann Surg. 2022;275(1):e52-e66.
Frederick MJ, Berhanu AE, Bartlett R. Chest surgery in female to male transgender individuals. Ann Plast Surg. 2017;78(3):249-253.
Wolter A, Scholz T, Pluto N, et al. Subcutaneous mastectomy in female-to-male transsexuals: optimizing perioperative and operative management in 8 years clinical experience. J Plast Reconstr Aesthet Surg. 2018;71(3):344-352.
Gooren LJ, van Trotsenburg MAA, Giltay EJ, et al. Breast cancer development in transsexual subjects receiving cross-sex hormone treatment. J Sex Med. 2013;10(12):3129-3134.
Burcombe RJ, Makris A, Pittam M, et al. Breast cancer after bilateral subcutaneous mastectomy in a female-to-male trans-sexual. Breast. 2003;12(4):290-293.
Nikolic DV, Djordjevic ML, Granic M, et al. Importance of revealing a rare case of breast cancer in a female to male transsexual after bilateral mastectomy. World J Surg Oncol. 2012;10:280.
Katayama Y, Motoki T, Watanabe S, et al. A very rare case of breast cancer in a female-to-male transsexual. Breast Cancer. 2016;23(6):939-944.
Brown A, Lourenco AP, Niell BL, et al.; Expert Panel on Breast Imaging. ACR Appropriateness Criteria® transgender breast cancer screening. J Am Coll Radiol. 2021;18(11S):S502-S515.
Ruddy KJ, Winer EP. Male breast cancer: risk factors, biology, diagnosis, treatment, and survivorship. Ann Oncol. 2013;24(6):1434-1443.
Patel DP, Goodwin IA, Acar O, et al. Masculinizing gender-affirming surgery for trans men and non-binary individuals: what you should know. Fertil Steril. 2021;116(4):924-930.
Jolly D, Wu CA, Boskey ER, et al. Is clitoral release another term for metoidioplasty? A systematic review and meta-analysis of metoidioplasty surgical technique and outcomes. Sex Med. 2021;9(1):100294.
Boczar D, Huayllani MT, Saleem HY, et al. Surgical techniques of phalloplasty in transgender patients: a systematic review. Ann Transl Med. 2021;9(7):607.
Heston AL, Esmonde NO, Dugi DD, et al. Phalloplasty: techniques and outcomes. Transl Androl Urol. 2019;8(3):254-265.
Rooker SA, Vyas KS, DiFilippo EC, et al. The rise of the neophallus: a systematic review of penile prosthetic outcomes and complications in gender-affirming surgery. J Sex Med. 2019;16(5):661-672.
Schardein JN, Zhao LC, Nikolavsky D. Management of vaginoplasty and phalloplasty complications. Urol Clin North Am. 2019;46(4):605-618.
Kovar A, Choi S, Iorio ML. Donor site morbidity in phalloplasty reconstructions: outcomes of the radial forearm free flap. Plast Reconstr Surg Glob Open. 2019;7(9):e2442.
Workowski KA, Bachmann LH, Chan PA, et al. Sexually transmitted infections treatment guidelines, 2021. MMWR Recomm Rep. 2021;70(4):1-187.
Perkins RB, Guido RS, Castle PE, et al. 2019 ASCCP risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors [published correction appears in J Low Genit Tract Dis. 2020; 24(4): 427]. J Low Genit Tract Dis. 2020;24(2):102-131.
Reisner SL, Deutsch MB, Peitzmeier SM, et al. Test performance and acceptability of self-versus provider-collected swabs for high-risk HPV DNA testing in female-to-male trans masculine patients. PLoS One. 2018;13(3):e0190172.
Hembree WC, Cohen-Kettenis PT, Gooren L, et al. Endocrine treatment of gender-dysphoric/gender-incongruent persons: an Endocrine Society clinical practice guideline [published corrections appear in J Clin Endocrinol Metab. 2018; 103(2): 699, and J Clin Endocrinol Metab. 2018; 103(7): 2758–2759]. J Clin Endocrinol Metab. 2017;102(11):3869-3903.
van der Sluis WB, Steensma TD, Bouman MB. Orchiectomy in transgender individuals: a motivation analysis and report of surgical outcomes. Int J Transgend Health. 2020;21(2):176-181.
Hontscharuk R, Alba B, Hamidian Jahromi A, et al. Penile inversion vaginoplasty outcomes: complications and satisfaction. Andrology. 2021;9(6):1732-1743.
Krempasky C, Grimstad FW, Harris M, et al. Feminizing gender-affirming surgery. J Gynecol Surg. 2021;37(4):283-290.
Grimstad F, McLaren H, Gray M. The gynecologic examination of the transfeminine person after penile inversion vaginoplasty. Am J Obstet Gynecol. 2021;224(3):266-273.
Ferrando CA. Vaginoplasty complications. Clin Plast Surg. 2018;45(3):361-368.
van der Sluis WB, de Haseth KB, Elfering L, et al. Neovaginal discharge in transgender women after vaginoplasty: a diagnostic and treatment algorithm. Int J Transgend Health. 2020;21(4):367-372.
Radix AE, Harris AB, Belkind U, et al. Chlamydia trachomatis infection of the neovagina in transgender women. Open Forum Infect Dis. 2019;6(11):ofz470.
Bodsworth NJ, Price R, Davies SC. Gonococcal infection of the neovagina in a male-to-female transsexual. Sex Transm Dis. 1994;21(4):211-212.
Elfering L, van der Sluis WB, Mermans JF, et al. Herpes neolabialis: herpes simplex virus type 1 infection of the neolabia in a transgender woman. Int J STD AIDS. 2017;28(8):841-843.
Hoebeke P, Selvaggi G, Ceulemans P, et al. Impact of sex reassignment surgery on lower urinary tract function. Eur Urol. 2005;47(3):398-402.
Kronawitter D, Gooren LJ, Zollver H, et al. Effects of transdermal testosterone or oral dydrogesterone on hypoactive sexual desire disorder in transsexual women: results of a pilot study. Eur J Endocrinol. 2009;161(2):363-368.
Cocchetti C, Ristori J, Mazzoli F, et al. Management of hypoactive sexual desire disorder in transgender women: a guide for clinicians. Int J Impot Res. 2020;33(7):703-709.
Jiang DD, Gallagher S, Burchill L, et al. Implementation of a pelvic floor physical therapy program for transgender women undergoing gender-affirming vaginoplasty. Obstet Gynecol. 2019;133(5):1003-1011.
Heller DS. Lesions of the neovagina—a review. J Low Genit Tract Dis. 2015;19(3):267-270.
Yamada K, Shida D, Kato T, et al. Adenocarcinoma arising in sigmoid colon neovagina 53 years after construction. World J Surg Oncol. 2018;16(1):88.
Hiroi H, Yasugi T, Matsumoto K, et al. Mucinous adenocarcinoma arising in a neovagina using the sigmoid colon thirty years after operation: a case report. J Surg Oncol. 2001;77(1):61-64.